The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGolden Rock Regulatory News (GCG)

  • This share is currently suspended. It was suspended at a price of 3.05

Share Price Information for Golden Rock (GCG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.05
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.05
GCG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

29 Sep 2023 07:00

RNS Number : 0619O
Golden Rock Global PLC
29 September 2023
 

 

 

 

 

Golden Rock Global plc

(Incorporated and registered in Jersey under the Companies (Jersey) Law 1991 with registered number 121560)

 

Unaudited Condensed Interim

Financial Statements

 

For the Period from 1st January 2023

to 30 June 2023

 

 

 

 

CHAIRMAN'S STATEMENT

 

 

It is a pleasure to announce the unaudited condensed interim financial statements for the Company for the period ended 30 June 2023. 

The key event during the period was the restoration of the Company's trading facility following the conclusion of discussions with Bolt Global Limited.

Post the period end there were two key events:

· The appointment of Clear Capital Limited as broker and a placing of new ordinary shares to raise £95,000 gross; and

· As announced on 17 August 2023, the Company entered into heads of terms with 2Mee Limited regarding a potential RTO, and the Company's shares were suspended. The Board is pleased to confirm that legal and financial due diligence in connection with the acquisition of 2Mee Limited is progressing well and we expect to have a complete submission to the FCA for an eligibility review of listing and a prospectus review in accordance with Listing Rule 5.6.21R by 1 December 2023.

As at 30 June 2023, the Company had cash of £54,000 and, post the fund raise announced on 20 July 2023, had cash in bank at 30 August 2023 of approximately £98,800. The Company has sufficient cash for its immediate requirements but will need to seek further funds or facilities if the acquisition of 2Mee Limited has not concluded in early 2024.

As announced on 5 December 2022, Wei Chen, a director, entered into a Loan Note Agreement for aggregate gross proceeds of £100,000. The maturity date of the agreement is 1 December 2023 and the Board are in discussions with Wei Chen regarding whether he wishes to convert the Loan Note in accordance with its terms or extend the maturity date. The Company will make an appropriate announcement in due course in line with its regulatory obligations.

On behalf of the Board, I thank shareholders for their continued support.

 

 

Ross Andrews

 

Chairman

 

Date: 29 September 2023

 

 

STATEMENT OF DIRECTORS' RESPONSIBILITIES

 

The directors confirm, to the best of their knowledge, that these condensed interim financial statements have been prepared in accordance with International Accounting Standard 34, 'Interim Financial Reporting', as adopted by the European Union and that the interim management report includes a fair review of the information required by DTR 4.2.7R and DTR 4.2.8R, namely:

· An indication of important events that have occurred during the first six months and their impact on the condensed set of financial statements and a description of the principal risks and uncertainties for the remaining six months of the financial year; and

· Material related party transactions in the first six months and any material changes in the related party transactions described in the last Annual Report and Accounts.

The directors of Golden Rock Global plc are listed in the Golden Rock Global plc Annual Report and Accounts 2022. A list of current directors is maintained on the website:

http://www.grglondon.com

 

By Order of the Board

 

 

Wei Chen

Executive Director

 

Date: 29 September 2023

 

CONDENSED STATEMENT OF COMPREHENSIVE INCOME

 

 

 

 

 

 

Note

 

6 months

ended

30/06/2023

 

£

 

 

6 months

ended

 30/06/2022

 

£

 

Administrative expenses

8

(94,663)

(62,179)

Other income

27,003

-

Operating loss

(67,660)

(62,179)

 

Finance income

 

-

 

 -

Finance costs

 (6,161)

(168)

Profit/(Loss) before taxation

(73,821)

(62,347)

 

Income tax expense

 

 

 

-

 

-

Profit/(Loss) for the period

(73,821)

(62,347)

 

 

 

Profit/(Loss) per share - basic and diluted (pence per share)

10

(0.39)

(0.33)

 

The notes on pages 7 to 13 form an integral part of these condensed financial statements.

CONDENSED STATEMENT OF FINANCIAL POSITION

As at 30 June 2023

Note

30/06/2023

 

£

 

 

31/12/2022

 

£

 

Current assets

Cash and cash equivalents

 

11

 

53,669

 

34,335

Other receivables

12

134,088

107,085

Total current assets

187,757

141,420

Total assets

187,757

141,420

 

Equity and liabilities

Capital and reserves attributable to owners of the company

Ordinary shares

 13

191,750

191,750

Share premium

13

1,605,788

1,605,788

Retained earnings

(1,874,568)

(1,800,747)

Total equity

(77,030)

(3,209)

 

Current liabilities

Trade creditors

156,587

101,102

Accruals

8,200

43,527

Convertible loan

14

100,000

-

Total current liabilities

264,787

144,629

Total equity and liabilities

187,757

141,420

 

These financial statements were approval by the Board of Directors for issue on 29 September 2023 and signed on behalf by:

 

 

Wei Chen

Executive Director

 

 

The notes on pages 7 to 13 form an integral part of these condensed financial statements.

 

 

CONDENSED STATEMENT OF CHANGES IN EQUITY

 

FOR THE PERIOD ENDED 30 JUNE 2023

 

 

Note

Share

capital

Share premium

 

Retained earnings

 

 

Total equity

 

£

£

£

 

 

£

Balance at 1 January 2023 13

191,750

1,605,788

 

(1,800,747)

(3,209)

 

 

 

 

 

 

 

 

Total comprehensive loss for the financial period

 

 

 

-

 

-

 

 

(73,821)

 

 

 

(73,821)

Balance at 30 June 2023 (Unaudited)

191,750

1,605,788

 

(1,874,568)

(77,030)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FOR THE PERIOD ENDED 30 JUNE 2022

 

 

Note

Share

capital

Share premium

 

Retained earnings

 

 

Total equity

 

£

£

£

 

£

Balance at 1 January 2022 13

191,750

1,605,788

 

(1,634,841)

162,697

 

 

 

 

 

 

 

 

Total comprehensive loss for the financial period

 

 

 

-

 

-

 

 

(62,347)

 

 

 

(62,347)

Balance at 30 June 2022 (Unaudited)

191,750

1,605,788

 

(1,697,188)

100,350

 

The notes on pages 7 to 13 form an integral part of these condensed financial statements.

 

 

CONDENSED STATEMENT OF CASH FLOWS

 

 

 

FOR THE PERIOD ENDED 30 JUNE 2023

 

 

 

 

Half Year to 30/06/2023

 

£

 

 

Half Year to 30/06/2022

 

£

 

Cash flows from operating activities

 

Operating profit/(loss)

(73,821)

(62,347)

 

Foreign exchange gain

-

-

 

(Increase)/Decrease in receivables

(27,003)

961

 

Increase/(Decrease) in payables

20,158

(20,000)

 

Net cash generated from operating activities

(80,666)

 

(81,386)

 

 

Cash flows from investing activities

 

Interest received

-

-

 

Net cash used in investing activities

-

 

-

 

 

Cash flows from financing activities

 

Proceeds from borrowings

100,000

-

 

Cash flows from financing activities

100,000

-

 

 

Net increase/(decrease) in cash, cash equivalents and bank overdrafts

 

19,334

 

 

(81,386)

 

Cash, cash equivalents and bank overdrafts at beginning of the half-year

34,335

182,974

 

Exchange gain/(losses) on cash and bank overdrafts

-

-

 

Cash, cash equivalents and bank overdrafts at end of the half-year

 

53,669

 

 

101,588

 

 

 

The notes on pages 7 to 13 form an integral part of these condensed financial statements.

 

NOTES TO THE UNAUDITED CONDENSED INTERIM FINANCIAL STATEMENTS

1. GENERAL INFORMATION

The Company was incorporated and registered in Jersey as a public company limited by shares on 17 June 2016 under the Companies (Jersey) Law 1991, as amended, with the name Golden Rock Global plc, and registered number 121560.

The Company's registered office is located at 11 Bath Street, St Helier, JE4 8UT, Jersey.

2. PRINCIPAL ACTIVITIES

The principal activity of the Company is to seek acquisition opportunities, initially focusing on the Fintech sector.

3. RECENT ACCOUNTING PRONOUNCEMENT 

a) New interpretations and revised standards effective for the period ended 30 June 2023

The Company has applied the same accounting policies and methods of computation in its interim financial statements as in its 2022 annual financial statements, except for those that relate to new standards and interpretations effective for the first time for periods beginning on (or after) 1 January 2023, and will be adopted in the 2023 annual financial statements. New standards impacting the Company that will be adopted in the annual financial statements for the year ending 31 December 2023, and which have given rise to changes in the Company's accounting policies are:

IFRS

Particular

Effective Date

Amendments to IAS 1

Classification of Liabilities as Current or Non-current

1st January 2023

Amendments to IAS 8

Definition of Accounting Estimates

1st January 2023

Amendments to IAS 12

Deferred Tax Related to Assets and Liabilities arising from a Single Transaction

1st January 2023

Amendments to IFRS 10 and IAS 28

Sale or Contribution of Assets between an Investor and its Associate or Joint Venture

Deferred indefinitely by amendments made in December 2015

Amendments to IFRS 17

Insurance Contracts

1st January 2023

 

b) Standards and interpretations in issue but not yet effective

 

There are a number of standards and interpretations which have been issued by the International Accounting Standards Board that are effective for periods beginning subsequent to 31 December 2023 (the date on which the company's next annual financial statements will be prepared up to) that the Company has decided not to adopt early. The Directors do not believe these standards and interpretations will have a material impact on the financial statements once adopted.

 

 

 

4. ACCOUNTING POLICIES

a) Basis of preparation

The condensed interim financial statements for the six months ended 30 June 2023 were approved by the Board of Directors on 28 September 2023. The condensed interim financial statements have been prepared in accordance with the Disclosure and Transparency Rules of the Financial Conduct Authority and International Accounting Standard 34 "Interim Financial Reporting" (IAS 34) as adopted by the European Union. The accounting policies applied by the company in these condensed interim financial statements are the same as those set out in the company's Annual Report and Accounts for the year ended 31 December 2022. No material new standards, amendments to standards or interpretations are effective in the period ended 30 June 2023.

 

The condensed interim financial statements are unaudited and have not been reviewed by the auditors. The financial information for the year ended 31 December 2022 does not constitute the Company's statutory financial statements. The Company's statutory financial statements for that year have been filed with the Jersey Registrar of Companies and received an unqualified auditor's report.

 

The condensed interim financial statements have been prepared on the going concern basis which assumes that the company will continue in operational existence for the foreseeable future on the grounds that the Directors will continue to financially support the company until such time as the business achieves financial viability. The company financial statements do not reflect any adjustments that would be required if they were to be prepared on a basis other than the going concern basis.

 

The financial information is presented in Pounds Sterling (£), which is the Company's functional and presentational currency.

 

b) Going Concern

The financial statements have been prepared on the assumption that the Company is a going concern. When assessing the foreseeable future, the directors have looked at a period of 12 months from the date of approval of this report. Despite cash being received post year end from the placing of new ordinary shares, the Company will need to raise additional funds in order to meet its day-to-day working capital requirements. The Directors are confident in their ability to raise sufficient capital from new shareholders or, if necessary, obtain alternative sources of funding. Whilst the Directors recognise that there is significant material uncertainty around going concern as a result of the trading results for the period to 30 June 2023, the accounts have still been prepared on a going concern basis, which is supported by confidence over the ability to raise sufficient funds through the issue of further equity should the need arise. 

 

c) Foreign currency translation

 

The financial statements of the Company are presented in the currency of the primary environment in which the Company operates (its functional currency).

Foreign currency transactions are translated into the functional currency using the exchange rates prevailing at the dates of the transactions. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation at year end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit and loss.

d) Financial instruments

Financial assets and financial liabilities are recognised in the Statement of Financial Position when the Company becomes a party to the contractual provisions of the instruments. Financial assets and financial liabilities are initially measured at fair value.

Transaction costs that are directly attributable to the acquisition or issue of financial assets and financial liabilities (other than financial assets and financial liabilities at fair value through profit or loss) are added to or deducted from the fair value of the financial assets or financial liabilities, as appropriate, on initial recognition.

Transaction costs directly attributable to the acquisition of financial assets or financial liabilities at fair value through profit or loss are recognised immediately in profit or loss.

Impairment of financial assets

An assessment for impairment is undertaken when there is objective evidence that a financial asset is impaired. Impairment loss on financial assets is recognised when there is objective evidence that the Company will not be able to collect all the amounts due to it in accordance with the original terms of the receivables. The amount of the impairment loss is determined as the difference between the asset's carrying amount and the present value of estimated future cash flows.

Financial liabilities

The Company's financial liabilities include amounts due to shareholders and other payables and accruals. Financial liabilities are recognised when the Company becomes a party to the contractual provision of the instrument. All financial liabilities are recognised initially at their fair value, net of transaction costs, and subsequently measured at amortised cost, using the effective interest method, unless the effect of discounting would be insignificant, in which case they are stated at cost.

The Company derecognises financial liabilities when, and only when, the Company's obligations are discharged, cancelled or they expire.

 

d) Cash and cash equivalents

Cash and cash equivalents includes cash in hand, deposits held on call with banks and other short term (having maturity within 3 months) highly liquid investments that are readily convertible into known amounts of cash and which are subject to an insignificant risk of changes in value.

e) Earnings per share

Basic earnings per share is computed using the weighted average number of shares outstanding during the period. Diluted earnings per share is computed using the weighted average number of shares during the period plus the dilutive effect of dilutive potential ordinary shares outstanding during the year.

 

5. ACCOUNTING ESTIMATES AND JUDGEMENTS

Preparation of financial information in conformity with IFRS requires management to make judgements, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. The estimates and associated assumptions are based on historical experience and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis of making judgements about carrying values of assets and liabilities that are not readily apparent from other sources.

 

It is the Directors' view that there are no significant areas of estimation, uncertainty and critical judgements in applying accounting policies that have significant effect on the amount recognised in the financial information for the period.

 

6. FINANCIAL RISK MANAGEMENT

a) Categories of financial instruments

The carrying amounts and fair value of the Company's financial assets and liabilities as at the end of the reporting year are as follows:

 

Half Year to 30/06/2023

 

Half Year to 30/06/2022

 

 

£

 

£

Financial assets at amortised cost

 

Loans and receivables (including cash and cash equivalents)

 

187,757

105,963

 

Financial liabilities at amortised cost

 

Financial liabilities at amortised cost

 

264,787

5,613

 

b) Financial risk management objectives and policies.

The Company is exposed to a variety of financial risks: market risk (including currency risk), credit risk and liquidity risk. The risk management policies employed by the Company to manage these risks are discussed below. The primary objectives of the financial risk management function are to establish risk limits, and then ensure that exposure to risk stays within these limits. The operational and legal risk management functions are intended to ensure proper functioning of internal policies and procedures to minimise operational and legal risks.

i) Market risk

Market risk is not material.

 

ii) Credit risk

 

Credit risk refers to the risk that a counterparty will default on its contractual obligations resulting in financial loss to the Company. Credit allowances are made for estimated losses that have been incurred by the reporting date.

 

iii) Liquidity risk

 

Liquidity risk is the risk that the Company will encounter difficulty in meeting the obligations associated with its financial liabilities. The Company's approach to managing liquidity is to ensure, as far as possible, that it will always have sufficient liquidity to meet its liabilities when due, under both normal and stressed conditions, without incurring unacceptable losses or risking damage to the Company's reputation.

 

7. SEGMENT REPORTING

 

IFRS 8 defines operating segments as those activities of an entity about which separate financial information is available and which are evaluated by the Board of Directors to assess performance and determine the allocation of resources. The Board of Directors are of the opinion that under IFRS 8 the Company has only one operating segment and one geographic market, in the UK. The Board of Directors assess the performance of the operating segment using financial information which is measured and presented in a manner consistent with that in the Financial Statements. Segmental reporting will be reviewed and considered in light of the development of the Company's business over the next reporting period.

 

8. STAFF COSTS AND KEY MANAGEMENT EMOLUMENTS

 

Half Year to 30/06/2023

£

 

 

 

 

Half Year to 30/06/2022

£

Key management emoluments

Remuneration

27,500

27,500

The half year remuneration of the key management was as follows, with no other cash or non-cash benefits.

 

£

 

 

 

 

Non-executive Directors

 

 

 

 

 

 

 

 

Ross Andrews

15,000

John Croft

12,500

27,500

 

9. TAXATION

The Company is incorporated in Jersey, and its activities are subject to taxation at a rate of 0%.

 

10.  EARNINGS PER SHARE

The Company presents basic and diluted earnings per share information for its ordinary shares. Basic earnings per share are calculated by dividing the profit or loss attributable to ordinary shareholders of the Company by the weighted average number of ordinary shares in issue during the reporting period. Diluted earnings per share are determined by adjusting the profit or loss attributable to ordinary shareholders and the weighted average number of ordinary shares outstanding for the effects of all dilutive potential ordinary shares.

There is no difference between the basic and diluted earnings per share, as the Company has no potential ordinary shares.

EARNINGS PER SHARE (CONT'D)

 

 

Half Year to 30/06/2023

 

Half Year to 30/06/2022

Profit/(Loss) attributable to ordinary shareholders

(73,821)

(62,347)

Weighted average number of shares

19,175,000

19,175,000

Earning/(loss) per share (expressed as pence per share)

 

 

 (0.39)

(0.33)

 

11.  CASH AND CASH EQUIVALENTS

 

30/06/2023

 

31/12/2022

 

£

 

 

£

 

Cash at bank equivalents

53,669

101,588

 

Cash at bank earns interest at floating rates based on daily bank deposit rates.

 

12. OTHER RECEIVABLES

 

30/06/2023

 

31/12/2022

 

£

 

 

£

 

Other receivables

134,088

107,085

 

Other receivables includes the transaction fees which were agreed to be payable by Bolt Global Limited from the previous proposed acquisition.

 

13. SHARE CAPITAL

 

Number of shares

Nominal

value

£

Authorised

 

Ordinary shares of GBP 0.01 each

48,000,000

480,000

 

 

Issued and fully paid

 

 

On incorporation

100

100

Subdivided share capital

9,900

-

10,000

100

Issue of shares upon placing

19,165,000

191,650

At 31 December 2022

 

At 30 June 2023

19,165,000

 

19,175,000

191,650

 

191,750

 

The issued shares have nominal value of each share of £0.01 and are fully paid. There are no restrictions on the distribution of dividends and the repayment of capital.

14. CONVERTIBLE LOAN

In December 2022, the Company announced that it had raised 12% unsecured convertible loan note instrument limited to an aggregate principal amount of £100,000. This loan was subsequently received on 10 January 2023.

Subject to the terms of the Instrument, the company has the right to either convert or repay the Notes by way of cash payment on the Maturity Date which is 1 December 2023.

15. CAPITAL MANAGEMENT

The Company manages its capital to ensure that it will be able to continue as a going concern while maximising the return to shareholders through the optimisation of the balance between debt and equity.

16. RELATED PARTY TRANSACTIONS

There is no ultimate controlling party.

The remuneration of the Directors, the key management personnel of the Company, is set out in note 8.

On 20 July 2003, after the reporting period, 400,000 warrants were granted to each of Ross Andrews and John Croft, directors of the Company. The warrants have an exercise price of 2.5 pence per share and an exercise period of three years from the date of grant. The warrants are only capable of being exercised on the earlier of 12 months from their issuance and the Company undertaking a transaction or other corporate event the completion of which would require the publication of a prospectus.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR FLFIRARITFIV
12
Date   Source Headline
13th Dec 202312:54 pmRNSExtension of Debt facility
29th Sep 20237:00 amRNSHalf-year Report
17th Aug 20237:39 amRNSProposed Transaction and Suspension of Listing
17th Aug 20237:30 amRNSSuspension - Golden Rock Global plc
26th Jul 20239:44 amRNSHolding(s) in Company
20th Jul 20234:36 pmRNSDirector/PDMR Shareholding
20th Jul 20237:00 amRNSFundraising and Broker Appointment
19th Jul 20237:00 amRNSUpdate on Potential Acquisition
28th Jun 20237:00 amRNSStmnt re Share Price Movement
12th Jun 20237:00 amRNSResult of AGM
28th Apr 20233:29 pmRNSAnnual Financial Report
5th Apr 20233:11 pmRNSRestoration of Trading
5th Dec 20227:00 amRNSIssue of Debt
18th Oct 20227:00 amRNSHalf-year Report
30th Sep 20223:46 pmRNSResult of AGM
14th Jun 20227:00 amRNSFinal Results
17th Nov 20217:40 amRNSStatement re. Suspension
16th Nov 20214:40 pmRNSSecond Price Monitoring Extn
16th Nov 20214:35 pmRNSPrice Monitoring Extension
16th Nov 20212:05 pmRNSSecond Price Monitoring Extn
16th Nov 20212:00 pmRNSPrice Monitoring Extension
15th Nov 202111:05 amRNSSecond Price Monitoring Extn
15th Nov 202111:00 amRNSPrice Monitoring Extension
12th Nov 20212:27 pmRNSHolding(s) in Company
26th Oct 20214:35 pmRNSHolding(s) in Company
27th Sep 20213:20 pmRNSHalf-year Report
20th Jul 202112:32 pmRNSResult of AGM
18th Jun 202110:30 amRNSNotice of AGM
7th May 20218:35 amRNSFinal Results
15th Apr 20212:06 pmRNSSecond Price Monitoring Extn
15th Apr 20212:01 pmRNSPrice Monitoring Extension
15th Mar 20214:41 pmRNSSecond Price Monitoring Extn
15th Mar 20214:35 pmRNSPrice Monitoring Extension
12th Mar 20212:05 pmRNSSecond Price Monitoring Extn
12th Mar 20212:00 pmRNSPrice Monitoring Extension
12th Mar 202111:06 amRNSSecond Price Monitoring Extn
12th Mar 202111:00 amRNSPrice Monitoring Extension
10th Mar 20214:00 pmRNSUpdate to Fundraising and expected Admission Date
8th Mar 20212:06 pmRNSSecond Price Monitoring Extn
8th Mar 20212:00 pmRNSPrice Monitoring Extension
8th Mar 202111:06 amRNSSecond Price Monitoring Extn
8th Mar 202111:00 amRNSPrice Monitoring Extension
5th Mar 20214:40 pmRNSSecond Price Monitoring Extn
5th Mar 20214:36 pmRNSPrice Monitoring Extension
5th Mar 20212:05 pmRNSSecond Price Monitoring Extn
5th Mar 20212:00 pmRNSPrice Monitoring Extension
23rd Feb 20214:33 pmRNSFundraising and Board Changes
10th Feb 202111:06 amRNSSecond Price Monitoring Extn
10th Feb 202111:00 amRNSPrice Monitoring Extension
10th Feb 20219:06 amRNSSecond Price Monitoring Extn
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.